Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.

Ole Kristian Lerche HelgestadJakob JosiassenChristian HassagerLisette Okkels JensenLene HolmvangNanna Louise Junker UdesenHenrik SchmidtHanne Berg RavnJacob Eifer Moller

Published in: Open heart (2020)

Use of MCS decreased by 50% from 2010 to 2017. Patients receiving MCS had more compromised haemodynamics in recent years. Early application of Impella CP was associated with reduced 30-day mortality compared with a matched control group.

Keyphrases

extracorporeal membrane oxygenation
cardiovascular events
risk factors
left ventricular assist device
cardiovascular disease
type diabetes